(5-((5-fluoropyridin-2-yloxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone,
filorexant,
MK-6096,
FILOREXANT,
1088991-73-4,
MK-6096,
MK 6096,
UNII-E6BTT8VA5Z,
MK6096,
E6BTT8VA5Z,
((2R,5R)-5-(((5-Fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone,
Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-methyl-2-(2-pyrimidinyl)phenyl)-,
Methanone, [(2R,5R)-5-[[(5-fluoro-2-pyridinyl)oxy]methyl]-2-methyl-1-piperidinyl][5-methyl-2-(2-pyrimidinyl)phenyl]-,
Filorexant [USAN:INN],
Filorexant (USAN),
Filorexant(mk-6096),
MK-6096; Filorexant,
GTPL4460,
SCHEMBL1716633,
CHEMBL2107822,
DTXSID50148764,
BDBM104692,
EX-A2101,
MFCD28100674,
ZINC43201232,
CS-4437,
DB12158,
SB16995,
NCGC00484077-01,
BC600579,
HY-15653,
US8569311, E-5,
FT-0772655,
Y1891,
D10345,
[(2R,5R)-5-[(5-fluoropyridin-2-yl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone,
Filorexant [USAN],
D0NN5A,
C24H25FN4O2,
N/A,